Quest Diagnostics Incorporated (DGX)
USD 168.15
(-2.87%)
USD 168.15
(-2.87%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.61 Billion USD | -19.7% |
| 2022 | 2 Billion USD | 9.68% |
| 2021 | 1.82 Billion USD | 9.99% |
| 2020 | 1.66 Billion USD | 13.99% |
| 2019 | 1.45 Billion USD | -2.8% |
| 2018 | 1.5 Billion USD | -17.81% |
| 2017 | 1.82 Billion USD | 4.89% |
| 2016 | 1.74 Billion USD | -1.75% |
| 2015 | 1.77 Billion USD | -2.42% |
| 2014 | 1.81 Billion USD | -0.22% |
| 2013 | 1.81 Billion USD | 0.1% |
| 2012 | 1.81 Billion USD | -14.3% |
| 2011 | 2.12 Billion USD | 20.73% |
| 2010 | 1.75 Billion USD | -1.04% |
| 2009 | 1.77 Billion USD | 0.21% |
| 2008 | 1.77 Billion USD | 7.74% |
| 2007 | 1.64 Billion USD | 13.78% |
| 2006 | 1.44 Billion USD | 13.02% |
| 2005 | 1.27 Billion USD | 3.55% |
| 2004 | 1.23 Billion USD | 5.16% |
| 2003 | 1.17 Billion USD | 8.37% |
| 2002 | 1.08 Billion USD | 1.73% |
| 2001 | 1.06 Billion USD | -6.25% |
| 2000 | 1.13 Billion USD | 54.69% |
| 1999 | 734.2 Million USD | 33.39% |
| 1998 | 550.4 Million USD | -4.86% |
| 1997 | 578.5 Million USD | -52.06% |
| 1996 | 1.2 Billion USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 406 Million USD | -6.88% |
| 2024 Q1 | 436 Million USD | 1.63% |
| 2024 Q3 | 481 Million USD | 18.47% |
| 2023 Q2 | 444 Million USD | -4.72% |
| 2023 FY | 1.61 Billion USD | -19.7% |
| 2023 Q1 | 466 Million USD | -25.2% |
| 2023 Q3 | 412 Million USD | -7.21% |
| 2023 Q4 | 429 Million USD | 4.13% |
| 2022 Q4 | 623 Million USD | 30.88% |
| 2022 FY | 2 Billion USD | 9.68% |
| 2022 Q3 | 476 Million USD | 4.85% |
| 2022 Q2 | 454 Million USD | 0.44% |
| 2022 Q1 | 452 Million USD | -7.76% |
| 2021 FY | 1.82 Billion USD | 9.99% |
| 2021 Q1 | 434 Million USD | -8.44% |
| 2021 Q2 | 452 Million USD | 4.15% |
| 2021 Q3 | 452 Million USD | 0.0% |
| 2021 Q4 | 490 Million USD | 8.41% |
| 2020 Q4 | 474 Million USD | -2.87% |
| 2020 Q3 | 488 Million USD | 51.08% |
| 2020 Q2 | 323 Million USD | -14.32% |
| 2020 Q1 | 377 Million USD | 26.09% |
| 2020 FY | 1.66 Billion USD | 13.99% |
| 2019 FY | 1.45 Billion USD | -2.8% |
| 2019 Q1 | 399 Million USD | 5.0% |
| 2019 Q2 | 381 Million USD | -4.51% |
| 2019 Q4 | 299 Million USD | -21.11% |
| 2019 Q3 | 379 Million USD | -0.52% |
| 2018 Q3 | 363 Million USD | -2.16% |
| 2018 FY | 1.5 Billion USD | -17.81% |
| 2018 Q1 | 386 Million USD | -18.39% |
| 2018 Q2 | 371 Million USD | -3.89% |
| 2018 Q4 | 380 Million USD | 4.68% |
| 2017 Q4 | 473 Million USD | 6.77% |
| 2017 Q3 | 443 Million USD | -2.42% |
| 2017 FY | 1.82 Billion USD | 4.89% |
| 2017 Q2 | 454 Million USD | -0.22% |
| 2017 Q1 | 455 Million USD | 7.06% |
| 2016 Q3 | 406 Million USD | -9.17% |
| 2016 Q1 | 462 Million USD | 0.43% |
| 2016 FY | 1.74 Billion USD | -1.75% |
| 2016 Q4 | 425 Million USD | 4.68% |
| 2016 Q2 | 447 Million USD | -3.25% |
| 2015 Q1 | 448 Million USD | 1.36% |
| 2015 FY | 1.77 Billion USD | -2.42% |
| 2015 Q4 | 460 Million USD | 9.26% |
| 2015 Q3 | 421 Million USD | -4.75% |
| 2015 Q2 | 442 Million USD | -1.34% |
| 2014 Q3 | 470 Million USD | 0.86% |
| 2014 Q4 | 442 Million USD | -5.96% |
| 2014 FY | 1.81 Billion USD | -0.22% |
| 2014 Q1 | 437 Million USD | 0.46% |
| 2014 Q2 | 466 Million USD | 6.64% |
| 2013 Q4 | 435 Million USD | -9.98% |
| 2013 Q3 | 483.2 Million USD | 11.52% |
| 2013 FY | 1.81 Billion USD | 0.1% |
| 2013 Q2 | 433.3 Million USD | -7.37% |
| 2013 Q1 | 467.8 Million USD | 7.24% |
| 2012 FY | 1.81 Billion USD | -14.3% |
| 2012 Q1 | 520.4 Million USD | 9.15% |
| 2012 Q3 | 453 Million USD | -1.86% |
| 2012 Q4 | 436.2 Million USD | -3.71% |
| 2012 Q2 | 461.6 Million USD | -11.3% |
| 2011 Q4 | 476.75 Million USD | 1.94% |
| 2011 FY | 2.12 Billion USD | 20.73% |
| 2011 Q1 | 457.6 Million USD | 1.83% |
| 2011 Q2 | 482 Million USD | 5.33% |
| 2011 Q3 | 467.7 Million USD | -2.97% |
| 2010 Q4 | 449.39 Million USD | 2.98% |
| 2010 FY | 1.75 Billion USD | -1.04% |
| 2010 Q1 | 440.5 Million USD | -1.6% |
| 2010 Q2 | 429.9 Million USD | -2.41% |
| 2010 Q3 | 436.4 Million USD | 1.51% |
| 2009 Q3 | 451.4 Million USD | 2.07% |
| 2009 FY | 1.77 Billion USD | 0.21% |
| 2009 Q4 | 447.64 Million USD | -0.83% |
| 2009 Q1 | 433.45 Million USD | -2.01% |
| 2009 Q2 | 442.23 Million USD | 2.02% |
| 2008 Q4 | 442.32 Million USD | 1.32% |
| 2008 Q1 | 445.74 Million USD | 7.23% |
| 2008 Q2 | 446.29 Million USD | 0.12% |
| 2008 Q3 | 436.54 Million USD | -2.19% |
| 2008 FY | 1.77 Billion USD | 7.74% |
| 2007 FY | 1.64 Billion USD | 13.78% |
| 2007 Q2 | 400 Million USD | 1.64% |
| 2007 Q3 | 434.48 Million USD | 8.62% |
| 2007 Q1 | 393.55 Million USD | 12.2% |
| 2007 Q4 | 415.68 Million USD | -4.33% |
| 2006 Q4 | 350.75 Million USD | -1.64% |
| 2006 Q1 | 387.88 Million USD | 17.73% |
| 2006 Q2 | 385.27 Million USD | -0.67% |
| 2006 Q3 | 356.6 Million USD | -7.44% |
| 2006 FY | 1.44 Billion USD | 13.02% |
| 2005 Q2 | 317.65 Million USD | 2.64% |
| 2005 FY | 1.27 Billion USD | 3.55% |
| 2005 Q4 | 329.47 Million USD | 2.45% |
| 2005 Q1 | 309.49 Million USD | 4.91% |
| 2005 Q3 | 321.6 Million USD | 1.24% |
| 2004 Q1 | 309.58 Million USD | 2.58% |
| 2004 FY | 1.23 Billion USD | 5.16% |
| 2004 Q2 | 309.46 Million USD | -0.04% |
| 2004 Q3 | 309.77 Million USD | 0.1% |
| 2004 Q4 | 295.01 Million USD | -4.76% |
| 2003 FY | 1.17 Billion USD | 8.37% |
| 2003 Q4 | 301.79 Million USD | 3.17% |
| 2003 Q3 | 292.51 Million USD | -1.88% |
| 2003 Q2 | 298.13 Million USD | 6.01% |
| 2003 Q1 | 281.22 Million USD | 4.48% |
| 2002 Q2 | 278.88 Million USD | 7.03% |
| 2002 Q1 | 260.55 Million USD | -3.42% |
| 2002 Q3 | 274.61 Million USD | -1.53% |
| 2002 Q4 | 269.16 Million USD | -1.98% |
| 2002 FY | 1.08 Billion USD | 1.73% |
| 2001 FY | 1.06 Billion USD | -6.25% |
| 2001 Q4 | 269.78 Million USD | 2.78% |
| 2001 Q3 | 262.49 Million USD | -2.28% |
| 2001 Q2 | 268.61 Million USD | -9.91% |
| 2001 Q1 | 298.16 Million USD | 13.17% |
| 2000 FY | 1.13 Billion USD | 54.69% |
| 2000 Q4 | 263.46 Million USD | -10.15% |
| 2000 Q3 | 293.21 Million USD | -0.95% |
| 2000 Q1 | 283.02 Million USD | 25.45% |
| 2000 Q2 | 296.03 Million USD | 4.6% |
| 1999 Q2 | 148.2 Million USD | 3.28% |
| 1999 Q1 | 143.5 Million USD | 3.02% |
| 1999 Q4 | 225.6 Million USD | 4.06% |
| 1999 FY | 734.2 Million USD | 33.39% |
| 1999 Q3 | 216.8 Million USD | 46.29% |
| 1998 Q3 | 140 Million USD | 5.03% |
| 1998 Q4 | 139.3 Million USD | -0.5% |
| 1998 FY | 550.4 Million USD | -4.86% |
| 1998 Q2 | 133.3 Million USD | -3.2% |
| 1998 Q1 | 137.7 Million USD | -7.71% |
| 1997 Q2 | 147.1 Million USD | 2.44% |
| 1997 Q4 | 149.2 Million USD | 7.57% |
| 1997 FY | 578.5 Million USD | -52.06% |
| 1997 Q1 | 143.6 Million USD | -76.14% |
| 1997 Q3 | 138.7 Million USD | -5.71% |
| 1996 Q4 | 601.9 Million USD | 105.36% |
| 1996 Q3 | 293.1 Million USD | 0.0% |
| 1996 FY | 1.2 Billion USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Agilent Technologies, Inc. | 2.11 Billion USD | 23.877% |
| Charles River Laboratories International, Inc. | 885.29 Million USD | -81.86% |
| Danaher Corporation | 8.83 Billion USD | 81.771% |
| Enzo Biochem, Inc. | 26.99 Million USD | -5863.626% |
| IQVIA Holdings Inc. | 2.05 Billion USD | 21.578% |
| Laboratory Corporation of America Holdings | 2.02 Billion USD | 20.352% |
| Mettler-Toledo International Inc. | 1.08 Billion USD | -47.789% |
| Qiagen N.V. | 777.67 Million USD | -107.027% |
| Revvity, Inc. | 874.01 Million USD | -84.207% |
| Thermo Fisher Scientific Inc. | 10.25 Billion USD | 84.299% |
| Waters Corporation | 943.51 Million USD | -70.638% |